Have a personal or library account? Click to login
Prevalence of papillary thyroid cancer in subacute thyroiditis patients may be higher than it is presumed: retrospective analysis of 137 patients Cover

Prevalence of papillary thyroid cancer in subacute thyroiditis patients may be higher than it is presumed: retrospective analysis of 137 patients

Open Access
|Sep 2018

References

  1. Fatourechi V, Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 2003; 88: 2100-5. 10.1210/jc.2002-021799
  2. Nishihara E, Amino N, Ohye H, Ota H, Ito M, Kubota S, et al. Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis. J Endocrinol Invest 2009; 32: 33-6. 10.1007/BF03345675
  3. Frates MC, Marqusee E, Benson CB, Alexander EK. Subacute granulomatous (de Quervain) thyroiditis: grayscale and color Doppler sonographic characteristics. J Ultrasound Med 2013; 32: 505-11. 10.7863/jum.2013.32.3.505
  4. Lee YJ, Kim DW. Sonographic characteristics and interval changes of subacute thyroiditis. J Ultrasound Med 2016; 35: 1653-9. 10.7863/ultra.15.09049
  5. Burman KD, Wartofsky L. Thyroid nodules. N Engl J Med 2015; 373: 2347-56. 10.1056/NEJMcp1415786
  6. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J 2017; 6: 225-37. 10.1159/000478927
  7. Lam KY, Lo CY. Papillary carcinoma with subacute thyroiditis. Endocr Pathol 2002; 13: 263-5.
  8. Nishihara E, Hirokawa M, Ohye H, Ito M, Kubota S, Fukata S, et al. Papillary carcinoma obscured by complication with subacute thyroiditis: sequential ultrasonographic and histopathological findings in five cases. Thyroid 2008; 18: 1221-5. 10.1089=thy.2008.0096
  9. Choia YS, Kima BK, Kwon HJ, Lee JS, Heo JJ, Jung SB, et al. Subacute lymphocytic thyroiditis with coexisting papillary carcinoma diagnosed by immediately repeat fine needle aspiration: a case report. J Med Cases 2012; 3: 308-11.
  10. Valentini RB, Macedo BM, Izquierdo RF, Meyer EL. Painless thyroiditis associated to thyroid carcinoma: role of initial ultrasonography evaluation. Arch Endocrinol Metab 2016; 60: 178-82. 10.1590/2359-3997000000104
  11. Ucan B, Delibasi T, Cakal E, Arslan MS, Bozkurt NC, Demirci T, et al. Papillary thyroid cancer case masked by subacute thyroiditis. Arq Bras Endocrinol Metabol 2014; 58: 851-4. 10.1590/0004-2730000003222
  12. Şenel F, Karaman H, Ertan T. Co-occurrence of subacute granulomatous thyroiditis and papillary microcarcinoma. Kulak Burun Bogaz Ihtis Derg 2016; 26: 248-50. 10.5606/kbbihtisas.2016.36776
  13. Gullu BE, Celik O, Gazioglu N, Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 2010; 13: 242-8. 10.1007/s11102-010-0224-9
  14. dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, et al. Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 2013; 16: 109-14. 10.1007/s11102-012-0383-y
  15. Wolinski K, Stangierski A, Dyrda K, Nowicka K, Pelka M, Iqbal A, et al. Risk of malignant neoplasms in acromegaly: a case-control study. J Endocrinol Invest 2017; 40: 319-22. 10.1007/s40618-016-0565-y
  16. Republic of Turkey Ministry of Health. Health Statistics Yearbook 2015 [cited 2017 Nov 15 ]; Available from: http://ekutuphane.sagem.gov.tr/kitaplar/health_statistics_yearbook_2015.pdf
  17. Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, et al. An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013. Jpn J Clin Oncol 2015; 45: 390-401. 10.1093/jjco/hyv002
  18. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140: 317-22. 10.1001/jamaoto.2014.1
  19. Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 2013; 23: 885-91. 10.1089/thy.2013.0045
  20. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol 2016; 12: 646-53. 10.1038/nrendo.2016.110
  21. Morris LG, Tuttle RM, Davies L. Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surg 2016; 142: 709-11. 10.1001/jamaoto.2016.0230
  22. Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP. Systematic review of trends in the incidence rates of thyroid cancer. Thyroid 2016; 26: 1541-52. 10.1089/thy.2016.0100
  23. Acar H, Cakabay B, Bayrak F, Evrenkaya T. Effects of the Chernobyl disaster on thyroid cancer incidence in Turkey after 22 years. ISRN Surg 2011; 2011: 257943. 10.5402/2011/257943
  24. Kocakusak A. Did Chernobyl accident contribute to the rise of thyroid cancer in Turkey? Acta Endo (Buc) 2016, 12: 362-67. 10.4183/aeb.2016.362
  25. Emral R, Baştemir M, Güllü S, Erdoğan G. Thyroid consequences of the Chernobyl nuclear power station accident on the Turkish population. Eur J Endocrinol 2003; 148: 497-503.
  26. Zengi A, Karadeniz M, Erdogan M, Ozgen AG, Saygili F, Yilmaz C, et al. Does Chernobyl accident have any effect on thyroid cancers in Turkey? A retrospective review of thyroid cancers from 1982 to 2006. Endocr J 2008; 55: 325-30. 10.1507/endocrj.K08E-007
  27. Ozdemir D, Dagdelen S, Kiratli P, Tuncel M, Erbas B, Erbas T. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster. Minerva Endocrinol 2012; 37: 267-74.
  28. Yildiz SY, Berkem H, Yuksel BC, Ozel H, Kendirci M, Hengirmen S. The rising trend of papillary carcinoma in thyroidectomies: 14-years of experience in a referral center of Turkey. World J Surg Oncol 2014; 12: 34. 10.1186/1477-7819-12-34
  29. Burgess JR. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 2002; 12: 141-9. 10.1089/105072502753522374
  30. Słowińska-Klencka D, Klencki M, Sporny S, Lewiński A. Fine-needle aspiration biopsy of the thyroid in an area of endemic goiter: influence of restored sufficient iodine supplementation on the clinical significance of cytological results. Eur J Endocrinol 2002; 146: 19-26.
  31. Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res 2015; 8: 8. 10.1186/s13044-015-0020-8
  32. Chen YK, Lin CL, Chang YJ, Cheng FT, Peng CL, Sung FC, et al. Cancer risk in patients with Graves’ disease: a nationwide cohort study. Thyroid 2013; 23: 879-84. 10.1089/thy.2012.0568
  33. Chen YK, Lin CL, Cheng FT, Sung FC, Kao CH. Cancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study. Br J Cancer 2013; 109: 2496-501. 10.1038/bjc.2013.597.
  34. Tam AA, Kaya C, Kiliç FB, Ersoy R, Çakir B. Thyroid nodules and thyroid cancer in Graves’ disease. Arq Bras Endocrinol Metabol 2014; 58: 933-8. 10.1590/0004-2730000003569
  35. Gul K, Dirikoc A, Kiyak G, Ersoy PE, Ugras NS, Ersoy R, et al. The association between thyroid carcinoma and Hashimoto’s thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid 2010; 20: 873-8. 10.1089/thy.2009.0118
  36. Anil C, Goksel S, Gursoy A. Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 2010; 20: 601-6. 10.1089/thy.2009.0450
  37. American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-214. 10.1089/thy.2009.0110
  38. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1-133. 10.1089/thy.2015.0020
  39. Ghossein RA, Leboeuf R, Patel KN, Rivera M, Katabi N, Carlson DL, et al. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid 2007; 17: 655-61. 10.1089=thy.2007.0061.
  40. Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid 2010; 20: 153-8. 10.1089/thy.2009.0352
DOI: https://doi.org/10.2478/raon-2018-0027 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 257 - 262
Submitted on: Mar 12, 2018
|
Accepted on: Jul 12, 2018
|
Published on: Sep 11, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Nurdan Gül, Ayşe Kubat Üzüm, Özlem Soyluk Selçukbiricik, Gülçin Yegen, Refik Tanakol, Ferihan Aral, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.